GSK-2194069 | B1571

GSK-2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS (human Fatty Acid Synthase).

GSK-2194069 is a potent and specific inhibitor of the β-ketoacyl reductase (KR) activity of hFAS (human Fatty Acid Synthase).

B1571 | GSK-2194069 DataSheet

Alternate Name/Synonyms: 4-[4-(benzofuran-5-yl)phenyl]-3-[[(3S)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]methyl]-1H-1,2,4-triazol-5-one;2-(hydroxymethyl)-2-(methoxymethyl)quinuclidin-3-one

Appearance: Crystalline solid

Formulation: N/A

CAS Number: 1332331-21-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: N/A

Molecular Formula: C₂₅H₂₄N₄O₃

Molecular Weight: 428.48

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A potent human Fatty Acid Synthase (FAS) inhibitor

MDL Number: N/A

PubChem CID: 67376285

SMILES: C1CC1C(=O)N2CCC(C2)CC3=NNC(=O)N3C4=CC=C(C=C4)C5=CC6=C(C=C5)OC=C6

InChi: InChI=1S/C25H24N4O3/c30-24(18-1-2-18)28-11-9-16(15-28)13-23-26-27-25(31)29(23)21-6-3-17(4-7-

InChi Key: AQTPWCUIYUOEMG-INIZCTEOSA-N